Vimarsana
Biggest News Aggregation in the World

Page 10 - Reference Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Reference Center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Reference Center Today - Breaking & Trending Today

Visitor industry pioneers to be honored - Vimarsana News

Visitor industry pioneers to be honored

Trustees of the Hawaii Hospitality Hall of Fame will celebrate the past by adding 14 more hospitality pioneers to a Wall of Fame at a gala later this month, while focusing on the future by raising funds for the University of Hawaii at Manoa School of Travel Industry Management.

International Expert Group Plans to Monitor Northern Sea Route Environment and Biodiversity - Vimarsana News

International Expert Group Plans to Monitor Northern Sea Route Environment and Biodiversity

Global collaboration is the key to an effective monitoring program for Northern Sea Route development.

Tour this babassu harvesters centre in Brazil - Vimarsana News

Tour this babassu harvesters centre in Brazil

A home for babassu harvesters by Estudio Flume in Brazil is centred on community

Iptacopan Meets Primary End Point of APPOINT-PNH Trial in Paroxysmal Nocturnal Hemoglobinuria - Vimarsana News

Iptacopan Meets Primary End Point of APPOINT-PNH Trial in Paroxysmal Nocturnal Hemoglobinuria

Iptacopan elicited improved hemoglobin levels measuring at least 2 g/dL higher vs baseline, leading to transfusion independence after 24 weeks in approximately 92.2% of patients with complement inhibitor–naïve paroxysmal nocturnal hemoglobinuria.

Source: ajmc.com
Trial Shows Iptacopan Lowers Need for Blood Transfusion in Almost All Patients With Paroxysmal Nocturnal Hemoglobinuria - Vimarsana News

Trial Shows Iptacopan Lowers Need for Blood Transfusion in Almost All Patients With Paroxysmal Nocturnal Hemoglobinuria

The APPOINT-PNH study showed that twice-daily LNP023 (Iptacopan) helped patients with paroxysmal nocturnal hemoglobinuria control intravascular hemolysis.